Skip to main content
. 2020 Aug 15;60(9):439–449. doi: 10.2176/nmc.oa.2020-0071

Table 2.

Comparison of the ASDH patients over 70 years between the endoscopy group and craniotomy group

Variables Endoscopy (n = 15) Craniotomy (n = 20) p value
Age (years) 86 (70–101) 80.5 (70–88) 0.06
 70–75, n (%) 2 (13%) 4 (20%)
 76–80, n (%) 2 (13%) 6 (30%)
 81–85, n (%) 3 (20%) 4 (20%)
 86–90, n (%) 5 (34%) 6 (30%)
 90+, n (%) 3 (20%) 0 (0%)
Women:men (% women) 9:6 (60%) 5:15 0.02*
Cause
 Fall, n (%) 12 (80%) 16 (80%)
 Traffic accident, n (%) 0 (0%) 2 (10%)
 Idiopathic, n (%) 3 (20%) 2 (10%)
Systolic blood pressure (mmHg) 167 (112–230) 166 (112–230) 0.44
Comorbidities
 Cerebrovascular diseases, n (%) 6 (40%) 6 (30%) 0.72
 Cardiovascular diseases, n (%) 6 (40%) 9 (45%) 0.99
 Hypertension, n (%) 3 (20%) 6 (30%) 0.70
 Diabetes mellitus, n (%) 1 (7%) 3 (15%) 0.62
 Use of antithrombotic drugs, n (%) 8 (53%) 14 (70%) 0.48
Premorbid mRS score 2 (0–4) 2.5 (0–4) 0.99
Chief complaint
 Impaired consciousness, n (%) 11 (73%) 16 (80%) 0.70
 Focal deficits, n (%) 3 (20%) 2 (10%) 0.63
 Headache, n (%) 1 (7%) 2 (10%) 0.99
Presence of light reflex, n (%) 11 (58%) 11 (55%) 0.31
GCS score on admission 8 (6–15) 7.5 (3–14) 0.46
 14–15, n (%) 1 (8%) 3 (15%)
 9–13, n (%) 6 (40%) 7 (35%)
 3–8, n (%) 8 (52%) 10 (50%)
Left:right (% left) 12:3 (80%) 7:13 (35%) 0.04*
Hematoma volume (mL) 140 (87–252) 121 (42–280) 0.15
Midline shift (mm) 12 (5–25) 11.4 (7–32) 0.91
Preop PT-INR 1.03 (0.80–3.86) 1.11 (0.91–2.87) 0.14
Postop PT-INR 1.21 (1.18–1.38, n = 4) 1.34 (1.08–1.71, n = 4) 0.88
Preop APTT (sec) 27.0 (21.6–49.1) 30.9 (23.3–49.4) 0.24
Postop APTT (sec) 35.0 (31.4–43.1, n = 3) 38.9 (37.3–42.5, n = 4) 0.63
Preop fibrinogen (mg/dL) 335 (162–566) 298 (139–513) 0.68
Postop fibrinogen (mg/dL) Not measured Not measured
Preop d-dimer (μg/mL) 5.5 (1.0–282.0) 10.7 (1.8–223.1) 0.27
Postop d-dimer (μg/mL) 3.5 (1.39–5.0, n = 8) 9.2 (2.5–15.8, n = 2) 0.53
Preop platelet count (104/μL) 17.4 (5.1–33.9) 14.3 (8.9–30.6) 0.33
Postop platelet count (104/μL) 16.7 (10.7–27.5) 11.5 (4.7–39.4, n = 18) 0.15
Transfusion of PC or FFP, n (%) 2 (13%) 3 (15%) 0.99
Time from trauma to operation (hr) 6 (1–48, n = 12) 14 (3–48, n = 19) 0.07
Bleeding amount (mL) 20 (5–400) 200 (10–2300) 0.002*
Operative time (min) 91 (48–156) 98 (61–267) 0.38
Stay time in the operation room (min) 120 (80–205) 180 (105–375) 0.005*
Hematoma removal rate 100% (90%–100%) 100% (96%–100%) 0.36
GCS score 7 days post-op 14 (3–15, n = 12) 12 (4–14, n =18) 0.36
mRS score at 6 months 5 (0–6) 5 (2–6) 0.91
Death during hospitalization, n (%) 3 (20%) 2 (10%) 0.63
Rebleeding, n (%) 2 (13%) 2 (10%) 0.99
Complication (bone infection), n (%) 0 (0%) 0 (0%) 0.99

The results are shown with the number (%) or the median (range). p value was calculated by the Fisher’s exact test or Mann–Whitney U test.

*

p <0.05.

APTT: activated partial thromboplastin time, ASDH: acute subdural hematoma, CT: computed tomography, FFP: fresh frozen plasma, GCS: Glasgow Coma Scale, mRS: modified Rankin Scale, PC: platelet concentrates, postop: post operation, preop: pre operation, PT-INR: prothrombin time international normalized ratio